A review of expenditure, outcomes, access to oncology medicines and oncology health systems in ten European countries
Abstract
Introduction. Substantial variation exists across Europe in cancer outcomes, health spending, and access to oncology medicines. The study aimed to collect and compare epidemiological indicators and data on oncological care in 10 selected European countries. Material and methods. A cross-national, targeted review of oncological data was undertaken to characterize key epidemiological and healthcare profiles in Poland, Czechia, Estonia, Germany, Spain, Slovenia, Netherlands, United Kingdom, Italy, and Finland. Data on health expenditure, site-standardized relative survival, and access to medicine were drawn from international sources (OECD, ECIS, EFPIA Wait Report and IHE Report). Summary of findings. In all the countries studied, the 2 leading causes of death were lung and colorectal cancer. Both incidence (537–690 cases per 100,000 population) and mortality rates (241–326 cases per 100,000 population) vary substantially in the selected countries. National cancer plans incorporating most of the elements stipulated in Europe’s Beating Cancer Plan have been implemented in every country. Among the selected countries in 2023, spending on cancer care accounted from 4% of total healthcare spending in Finland, to 8% in Germany and Poland. Poland shows the lowest levels of cancer screening, with breast cancer screening reaching only 37% of women ( vs. 82% in Finland) and cervical cancer screening was as low as 11% (compared with 77% in Czechia). Conclusions. Improving oncology system performance requires strategic resource allocation and is crucial to the impact analysis on population outcomes. The access granted to health services without a long-term strategy in implementation and prospective evaluation to value-based cancer care should be in compliance according to the Beating Cancer Plan. The level of integration, equity in access also at a regional level, not only on the country level is crucial to shaping health care in Europe.
Fields of Study & Subjects
Global Cancer Incidence and Screening
Economic and Financial Impacts of Cancer
Advances in Oncology and Radiotherapy
Publication details
- Journal / source
- Oncology in Clinical Practice
- Volume
- 22
- Issue
- 0
- Publication date
- 15 January 2026
- Language
- EN